Picture of Sedana Medical AB (publ) logo

SEDANA Sedana Medical AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Brief: Sedana Medical Sees Increased Demand As A Result Of COVID-19 Pandemic

March 30 (Reuters) - Sedana Medical AB (publ)  SEDANA.ST :
    * SEDANA MEDICAL SEES INCREASED DEMAND AND KEEPS TIME
SCHEDULE
    * COMPANY SEES INCREASED DEMAND FOR ANACONDA AS A RESULT OF
COVID-19 PANDEMIC AND SO FAR, HAS HAD NO SIGNIFICANT SUPPLY
CHAIN DISRUPTIONS
    * FORECASTS A SALES INCREASE OF ABOUT 50 PERCENT FOR Q1 OF
2020
AND ABOUT 100 PERCENT FOR MONTH OF MARCH, COMPARED TO SAME
PERIODS LAST YEAR
    * DUE TO COVID-19 PANDEMIC SEDANA MEDICAL SEES A SLIGHT RISK
OF
DELAY OF COMPILATION OF ISOCONDA STUDY UNTIL BEGINNING OF Q3 OF
2020
    * STILL EXPECTS TO KEEP TIMETABLE AND SUBMIT APPLICATION IN
Q3, OR
EARLY IN Q4 OF 2020 AND AN APPROVAL DURING SECOND HALF OF 2021

Source text for Eikon:  ID:nWkr1x7BkK 
Further company coverage:  SEDANA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Sedana Medical AB (publ)

See all news